Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

November 23, 2018

In re: REMICADE

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 21, 2019

    3rd Circ. Declines To Reconsider J&J Remicade Antitrust Case

    The full Third Circuit on Monday declined to reconsider a panel's September ruling sending antitrust claims from Rochester Drug Cooperative Inc. over allegedly inflated prices it paid for the Johnson & Johnson immunosuppressant Remicade to arbitration, denying RDC's petition for a rehearing en banc filed earlier this month.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login